• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用非肝系细胞系突出了与基于细胞的代谢诱导毒性评估相关的局限性。

Use of a non-hepatic cell line highlights limitations associated with cell-based assessment of metabolically induced toxicity.

机构信息

Faculty of Pharmacy, Rhodes University, Grahamstown, South Africa.

Biomedical Biotechnology Research Unit, Rhodes University, Grahamstown, South Africa.

出版信息

Drug Chem Toxicol. 2020 Nov;43(6):656-662. doi: 10.1080/01480545.2019.1585869. Epub 2019 Mar 18.

DOI:10.1080/01480545.2019.1585869
PMID:30880486
Abstract

Metabolically induced drug-toxicity is a major cause of drug failure late in drug optimization phases. Accordingly, metabolic profiling of compounds is being introduced at earlier stages of the drug discovery pipeline. An increasingly common method to obtain these profiles is through overexpression of key CYP450 metabolic enzymes in immortalized liver cells, to generate competent hepatocyte surrogates. Enhanced cytotoxicity is presumed to be due to toxic metabolite production via the overexpressed enzyme. However, metabolically induced toxicity is a complex multi-parameter phenomenon and the potential background contribution to metabolism arising from the use of liver cells which endogenously express CYP450 isoforms is consistently overlooked. In this study, we sought to reduce the potential background interference by applying this methodology in kidney-derived HEK293 cells which lack endogenous CYP450 expression. Overexpression of CYP3A4 resulted in increased HEK293 proliferation, while exposure to four compounds with reported metabolically induced cytotoxicity in liver-derived cells overexpressing CYP3A4 resulted in no increase in cytotoxicity. Our results indicate that overexpression of a single CYP450 isoform in hepatic cell lines may not be a reliable method to discriminate which enzymes are responsible for metabolic induced cytotoxicity.

摘要

代谢诱导的药物毒性是药物优化后期药物失败的主要原因。因此,在药物发现管道的早期阶段引入了化合物的代谢分析。获得这些图谱的一种越来越常见的方法是通过在永生化肝细胞中过度表达关键的 CYP450 代谢酶,生成有能力的肝细胞替代物。假定增强的细胞毒性是由于通过过度表达的酶产生有毒代谢物。然而,代谢诱导的毒性是一种复杂的多参数现象,并且由于使用内源性表达 CYP450 同工型的肝细胞而产生的潜在背景对代谢的贡献一直被忽视。在这项研究中,我们试图通过在缺乏内源性 CYP450 表达的肾源性 HEK293 细胞中应用这种方法来减少潜在的背景干扰。CYP3A4 的过度表达导致 HEK293 细胞增殖增加,而暴露于四种在过表达 CYP3A4 的肝源性细胞中报告具有代谢诱导细胞毒性的化合物不会导致细胞毒性增加。我们的结果表明,在肝系细胞系中过度表达单一 CYP450 同工型可能不是区分哪些酶负责代谢诱导细胞毒性的可靠方法。

相似文献

1
Use of a non-hepatic cell line highlights limitations associated with cell-based assessment of metabolically induced toxicity.使用非肝系细胞系突出了与基于细胞的代谢诱导毒性评估相关的局限性。
Drug Chem Toxicol. 2020 Nov;43(6):656-662. doi: 10.1080/01480545.2019.1585869. Epub 2019 Mar 18.
2
A correlation between the in vitro drug toxicity of drugs to cell lines that express human P450s and their propensity to cause liver injury in humans.在表达人 P450 的细胞系中,药物的体外药物毒性与它们在人体中引起肝损伤的倾向之间存在相关性。
Toxicol Sci. 2014 Jan;137(1):189-211. doi: 10.1093/toxsci/kft223. Epub 2013 Oct 1.
3
Development of an optimized cytotoxicity assay system for CYP3A4-mediated metabolic activation via modified piggyBac transposition.通过改良的piggyBac转座开发用于CYP3A4介导的代谢活化的优化细胞毒性检测系统。
Toxicol In Vitro. 2016 Apr;32:132-7. doi: 10.1016/j.tiv.2015.12.008. Epub 2015 Dec 17.
4
Human Hepatic HepaRG Cells Maintain an Organotypic Phenotype with High Intrinsic CYP450 Activity/Metabolism and Significantly Outperform Standard HepG2/C3A Cells for Pharmaceutical and Therapeutic Applications.人肝HepaRG细胞保持具有高内在CYP450活性/代谢的器官样表型,并且在药物和治疗应用方面显著优于标准的HepG2/C3A细胞。
Basic Clin Pharmacol Toxicol. 2017 Jan;120(1):30-37. doi: 10.1111/bcpt.12631. Epub 2016 Jul 15.
5
The role of CYP 3A4 and 1A1 in amiodarone-induced hepatocellular toxicity.细胞色素P450 3A4和1A1在胺碘酮诱导的肝细胞毒性中的作用。
Toxicol Lett. 2016 Jun 24;253:55-62. doi: 10.1016/j.toxlet.2016.04.016. Epub 2016 Apr 22.
6
Methodologies for investigating drug metabolism at the early drug discovery stage: prediction of hepatic drug clearance and P450 contribution.早期药物发现阶段药物代谢研究方法:肝清除率和 P450 贡献预测。
Curr Drug Metab. 2010 Oct;11(8):678-85. doi: 10.2174/138920010794233503.
7
Bioactive components of Glycyrrhiza uralensis mediate drug functions and properties through regulation of CYP450 enzymes.甘草的生物活性成分通过调节细胞色素P450酶来介导药物的功能和特性。
Mol Med Rep. 2014 Sep;10(3):1355-62. doi: 10.3892/mmr.2014.2331. Epub 2014 Jun 16.
8
A novel in vitro approach for simultaneous evaluation of CYP3A4 inhibition and kinetic aqueous solubility.一种同时评估CYP3A4抑制作用和动力学水溶解度的新型体外方法。
J Biomol Screen. 2015 Feb;20(2):254-64. doi: 10.1177/1087057114552796. Epub 2014 Oct 8.
9
Development of a highly sensitive cytotoxicity assay system for CYP3A4-mediated metabolic activation.开发一种用于 CYP3A4 介导的代谢活化的高灵敏度细胞毒性测定系统。
Drug Metab Dispos. 2011 Aug;39(8):1388-95. doi: 10.1124/dmd.110.037077. Epub 2011 May 3.
10
Marsdenia tenacissima extract inhibits gefitinib metabolism in vitro by interfering with human hepatic CYP3A4 and CYP2D6 enzymes.密花紫玉盘提取物通过干扰人肝 CYP3A4 和 CYP2D6 酶来抑制体外吉非替尼的代谢。
J Ethnopharmacol. 2014;151(1):210-7. doi: 10.1016/j.jep.2013.10.021. Epub 2013 Oct 21.

引用本文的文献

1
Continual proteomic divergence of HepG2 cells as a consequence of long-term spheroid culture.长期球体培养导致 HepG2 细胞的蛋白质组持续分化。
Sci Rep. 2021 May 25;11(1):10917. doi: 10.1038/s41598-021-89907-9.